Skip to main content
Premium Trial:

Request an Annual Quote

Response Genetics to Partner with UCSF on Pancreatic Cancer Dx Development

NEW YORK (GenomeWeb News) - Response Genetics today said it will work with the University of California, San Francisco, on a two-year research study aimed at developing a diagnostic test kit for pancreatic cancer.
 
The company said the study will combine data from patient outcomes with genetic information from formalin-fixed paraffin-embedded samples of pancreatic tissue provided by UCSF.
 
Response Genetics will cover the costs of the project, while Margaret Tempero, deputy director of the UCSF Comprehensive Cancer Center, will lead the investigation.
 
"Diagnostics tests emerging from this collaboration would help physicians tailor treatment to the individual by using genetic information to identify patients who would most benefit from surgery or chemotherapy and radiation," Response Genetics President and CEO Kathleen Danenberg said in a statement.

The Scan

Self-Reported Hearing Loss in Older Adults Begins Very Early in Life, Study Says

A JAMA Otolaryngology — Head & Neck Surgery study says polygenic risk scores associated with hearing loss in older adults is also associated with hearing decline in younger groups.

Genome-Wide Analysis Sheds Light on Genetics of ADHD

A genome-wide association study meta-analysis of attention-deficit hyperactivity disorder appearing in Nature Genetics links 76 genes to risk of having the disorder.

MicroRNA Cotargeting Linked to Lupus

A mouse-based study appearing in BMC Biology implicates two microRNAs with overlapping target sites in lupus.

Enzyme Involved in Lipid Metabolism Linked to Mutational Signatures

In Nature Genetics, a Wellcome Sanger Institute-led team found that APOBEC1 may contribute to the development of the SBS2 and SBS13 mutational signatures in the small intestine.